Abstract
Currently, no pharmaceuticals for the etiological treatment of neurodegenerative protein-misfolding diseases (e.g., ALS, Alzheimers or prion diseases) are available. In this brief communication the development of chaperone-based medications from medicinal plants (e.g., Ginkgo biloba) are reviewed as referred to specific protein-protein interactions of plant metallochaperones and human enzymes. It is indicated that bioactive copper chaperones for superoxide dismutase isolated from medicinal plants may be lead molecules for drug development in several diseases concerning metal ion metabolisms of man and animals.
Keywords: Metallophytochaperones, blood, Alzheimer's disease, plant extracts, CCS, Ginkgo biloba, SOD, apoenzymes, plant molecular farming, metal ion homeostasis
Protein & Peptide Letters
Title: Medicinal Plants: A Natural Chaperones Source for Treating Neurological Disorders
Volume: 16 Issue: 2
Author(s): Bernd Kastenholz and David E. Garfin
Affiliation:
Keywords: Metallophytochaperones, blood, Alzheimer's disease, plant extracts, CCS, Ginkgo biloba, SOD, apoenzymes, plant molecular farming, metal ion homeostasis
Abstract: Currently, no pharmaceuticals for the etiological treatment of neurodegenerative protein-misfolding diseases (e.g., ALS, Alzheimers or prion diseases) are available. In this brief communication the development of chaperone-based medications from medicinal plants (e.g., Ginkgo biloba) are reviewed as referred to specific protein-protein interactions of plant metallochaperones and human enzymes. It is indicated that bioactive copper chaperones for superoxide dismutase isolated from medicinal plants may be lead molecules for drug development in several diseases concerning metal ion metabolisms of man and animals.
Export Options
About this article
Cite this article as:
Kastenholz Bernd and Garfin E. David, Medicinal Plants: A Natural Chaperones Source for Treating Neurological Disorders, Protein & Peptide Letters 2009; 16 (2) . https://dx.doi.org/10.2174/092986609787316234
DOI https://dx.doi.org/10.2174/092986609787316234 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease
Current Topics in Medicinal Chemistry Differentiating the Dementias. Revisiting Synucleinopathies and Tauopathies
Current Alzheimer Research Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review
Current Drug Targets Ischemic Post-Conditioning Partially Reverses Cell Cycle Reactivity Following Ischemia/Reperfusion Injury: A Genome-Wide Survey
CNS & Neurological Disorders - Drug Targets Editorial [Hot topic: Alzheimers Disease Drug Discovery: Aβ and Beyond (Guest Editors: D.W. Shineman and H.M. Fillit)]
Current Alzheimer Research Neurochemistry Changes Associated with Mutations in Familial Parkinsons Disease
Current Medicinal Chemistry A Review of Wavelet Denoising in MRI and Ultrasound Brain Imaging
Current Medical Imaging Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Current Pharmaceutical Design Bioinformatics Approach to BDNF and BDNF-Related Disorders
Current Neuropharmacology Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Current Drug Targets - CNS & Neurological Disorders Inducers of Heme Oxygenase-1
Current Pharmaceutical Design Prion Protein Misfolding and Brain Degeneration
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Current Pharmaceutical Design Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Anti-inflammatory Treatment of Acute Coronary Syndromes
Current Pharmaceutical Design Effect of S-equol and Soy Isoflavones on Heart and Brain
Current Cardiology Reviews Editorial (Hot Topic: Fragile X Families: A Lifespan Perspective)
Current Psychiatry Reviews Assessment of Mobility Status and Risk of Mobility Disability in Older Persons
Current Pharmaceutical Design Novel Anti-Platelets in Stable Coronary Artery Disease
Current Pharmaceutical Design Inflammatory Cardiovascular Risk Markers in Obstructive Sleep Apnoea Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry